Regeneron Pharmaceuticals, Inc.
USD630.24
-1.57 (-0.25%)
CEO
Leonard S. Schleifer
IPO Date
1991-04-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$630.95
Prev. Close
$631.81
Day Low
$627.07
Day High
$634.06
52W Low
$521.00
52W High
$821.11
Market Cap
$64.93B
Volume
0.03M
| 17.4 |
| 31 Dec 2023 | FY | 82.9% | 30.1% | 15.2% | 12.0% | 0.10 | 5.69 | 23.7 |
| 31 Dec 2022 | FY | 86.0% | 35.6% | 19.1% | 14.9% | 0.12 | 5.06 | 17.8 |
| 31 Dec 2021 | FY | 83.1% | 50.2% | 43.0% | 31.7% | 0.14 | 3.56 | 8.3 |
| 31 Dec 2020 | FY | 84.0% | 41.3% | 31.9% | 20.5% | 0.24 | 3.63 | 14.8 |
| 31 Dec 2019 | FY | 85.1% | 32.3% | 19.1% | 14.3% | 0.06 | 3.67 | 19.4 |
| 31 Dec 2018 | FY | 91.3% | 36.4% | 27.9% | 20.8% | 0.08 | 5.52 | 17.5 |
| 31 Dec 2017 | FY | 90.8% | 20.4% | 19.5% | 13.7% | 0.11 | 4.93 | 36.4 |
| 31 Dec 2016 | FY | 91.7% | 18.4% | 20.1% | 12.8% | 0.11 | 3.15 | 47.7 |
| 23.5 |
| 30 Sept 2025 | Q3 | 86.1% | 38.9% | 4.7% | 3.6% | 0.09 | 4.06 | 10.0 |
| 30 Jun 2025 | Q2 | 85.6% | 37.9% | 4.6% | 3.6% | 0.09 | 4.60 | 9.9 |
| 31 Mar 2025 | Q1 | 84.7% | 26.7% | 2.8% | 2.2% | 0.09 | 4.93 | 20.9 |
| 31 Dec 2024 | Q4 | 85.1% | 24.2% | 3.1% | 2.4% | 0.09 | 4.73 | 20.9 |
| 30 Sept 2024 | Q3 | 86.8% | 36.0% | 4.6% | 3.6% | 0.09 | 5.28 | 21.2 |
| 30 Jun 2024 | Q2 | 86.5% | 40.4% | 5.1% | 4.0% | 0.10 | 5.44 | 19.9 |
| 31 Mar 2024 | Q1 | 86.2% | 23.0% | 2.7% | 2.1% | 0.10 | 5.27 | 36.2 |
| 31 Dec 2023 | Q4 | 81.7% | 33.8% | 4.5% | 3.5% | 0.10 | 5.69 | 20.2 |